Tag Archives: immune system

Early Oncology Partnering Forum

Posted on 15 February 2011 by Evan Richardson

From 21-22 February 2011, Cato Research will be attending the Early Oncology Partnering Forum held in San Francisco, CA.  This conference facilitates and encourages discussion and collaborations between companies that are developing innovative products with more established companies as partners. … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , , , , , | Comments Off

Cato at the 12th World Congress on Gastrointestinal Cancer

Posted on 30 June 2010 by Evan Richardson

Cato Research will be attending the European Society for Medical Oncology‘s (ESMO)  12th World Congress on Gastrointestinal Cancer in Barcelona, Spain from 30 June to 03 July 2010.  ESMO is the leading European professional organization representing medical oncologists.  The conference … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , | Comments Off

Cato at the Cancer Vaccines Meeting

Posted on 29 June 2010 by Evan Richardson

This week, Cato Research is attending the Cancer Vaccines meeting in Cambridge, MA on 29 and 30 June.  The conference is the first meeting dedicated to progressing cancer vaccines to market and will feature 21 of the world’s leading experts … Continue reading →

Posted in Conferences and Meetings | Tagged , , , , , , | Comments Off

Approval of Therapeutic Cancer Vaccines

Posted on 12 May 2010 by Ask-Cato.com Contributor

Last month, Dendreon was granted approval for Provenge®, the first cell based cancer vaccine for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  Provenge is the first cancer treatment that utilizes the strength of the … Continue reading →

Posted in FDA, Industry News, Publications | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment